Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer
选择性腺苷A2B拮抗剂PBF-1129治疗转移性非小细胞肺癌患者的I期剂量递增试验
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-025-01591-y
Owen, Dwight H; Wu, Ruohan; Wei, Lai; Dikov, Mikhail; Suman, Shankar; Su, Po-Lan; Amann, Joseph; Guan, Shuxiao; Spakowicz, Daniel; Schweitzer, Catherine; Pilcher, Carly; Smith, Michael B; Ferguson, Sarah; Palomino, Julio Castro; Pérez, Santiago Figueroa; Bertino, Erin M; Shields, Peter G; He, Kai; Presley, Carolyn J; Otterson, Gregory A; Carson, William E; Carbone, David P